Biotech lab testing plans for a novel probiotic candidate exploring muscle preservation during GLP-1 weight-loss strategies.
Key Takeaways
- Independent flow cytometry program will quantitatively characterize EL-22 antigen expression
- Tests will use antibody-based detection plus live/dead cell analysis across sample panels
- Work will be conducted by an independent contract research organization with data generation planned